Interestingly, the addition of purified Wnt1 activates β-catenin and protects CML cells from TKI treatment, thus confirming the important role of Wnt pathway in maintaining CML stem cells (Zhang et al., 2013). The gene discussed is WNT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.